# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-25-269483
Filing Date
2025-11-06
Accepted
2025-11-06 16:08:13
Documents
59
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | vivs-20250930.htm iXBRL | 10-Q | 2275752
2 | EX-31.1 | vivs-ex31_1.htm | EX-31.1 | 14063
3 | EX-31.2 | vivs-ex31_2.htm | EX-31.2 | 14031
4 | EX-32.1 | vivs-ex32_1.htm | EX-32.1 | 11688
| Complete submission text file | 0001193125-25-269483.txt |  | 8176959

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | vivs-20250930.xsd | EX-101.SCH | 1170107
61 | EXTRACTED XBRL INSTANCE DOCUMENT | vivs-20250930_htm.xml | XML | 1258079

Mailing Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121
Business Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121 858-224-1000
VivoSim Labs, INC. (Filer) CIK: 0001497253 (see all company filings)

EIN.: 271488943 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-35996 | Film No.: 251458265
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)